The following companies are expected to report earnings prior to market open on 04/01/2026. Visit our Earnings Calendar for a full list of expected earnings releases.ConAgra Brands, Inc. (CAG)is reporting for the quarter ending February 28, 2026. The food company's consensus ear
The following companies are expected to report earnings prior to market open on 04/01/2026. Visit our Earnings Calendar for a full list of expected earnings releases.ConAgra Brands, Inc. (CAG)is reporting for the quarter ending February 28, 2026. The food company's consensus ear
Dmitry Vinogradov/iStock Editorial via Getty Images Stocks plummeted in March as the war in Iran sent oil prices ( CO1:COM ) soaring, but geopolitical rays of hope emerged to close the quarter. The S&P 500 ETF (SP500, SPY) fell more than 5%, nearly its worst month since September 2022. Despite a powerful 'Turnaround Tuesday' to finish the first quarter, it was red across the board, away from Energ...
Dmitry Vinogradov/iStock Editorial via Getty Images Stocks plummeted in March as the war in Iran sent oil prices ( CO1:COM ) soaring, but geopolitical rays of hope emerged to close the quarter. The S&P 500 ETF (SP500, SPY) fell more than 5%, nearly its worst month since September 2022. Despite a powerful 'Turnaround Tuesday' to finish the first quarter, it was red across the board, away from Energy. The Nasdaq 100 ETF ( QQQ ) shed 5%, very close to the declines in mid-caps ( MDY ) and the Russell 2000 ETF ( IWM ). Foreign stocks were hit even harder. The Vanguard FTSE All-World ex-US ETF ( VEU ) slid 9%, with emerging markets feeling the brunt of higher Brent and WTI crude oil prices. In the bond market, the yield on the benchmark 10-year Treasury rate climbed 34 basis points to 4.30%. The positive stock-bond correlation was negative news for the iShares Core US Aggregate Bond ETF ( AGG ), which suffered a 2% March decline (dividends included). Global oil obviously took off, resulting in a 53% monthly increase in the United States Oil Fund ( USO )--its best month on record (even with a loss on the 31 st ). Oil’s gain contrasted with a massive 12% decline in gold ( GLD ). The yellow metal had a hot start to the year but is now down nearly 20% from its January all-time high. Finally, bitcoin ( IBIT ) perhaps surprisingly rallied 3% in March, all while the US Dollar ETF ( UUP ) added 3%. Oil's March Jolt Stunned Stocks StockCharts.com Digging into the sector view, Energy ( XLE ) was the big winner—no surprises there. Up more than 10% for March, oil & gas equities lagged physical oil in a major way. Still, XLE’s rise looked very strong compared to the 10 other S&P 500 sector ETFs. Worst among them was Industrials ( XLI ), which lost 9%. Steam was let out of the AI trade to an extent, while profit-taking in the Aerospace & Defense industry stymied XLI. Interestingly, defensive sectors failed to provide safety. Utilities ( XLU ) was "least bad," down 4%. But Real Estate (...
Treasury Secretary Scott Bessent ’s benchmark financial asset — 10-year US Treasuries — are poised to mark their biggest monthly tumble since Donald Trump returned to the White House, casting a shadow over the economic outlook as the administration struggles to contain an energy crisis. While Bessent has assured that the global oil deficit caused by the Iran war is being addressed , and predicted ...
Treasury Secretary Scott Bessent ’s benchmark financial asset — 10-year US Treasuries — are poised to mark their biggest monthly tumble since Donald Trump returned to the White House, casting a shadow over the economic outlook as the administration struggles to contain an energy crisis. While Bessent has assured that the global oil deficit caused by the Iran war is being addressed , and predicted crude prices will retreat within months, investors are flagging enduring concern. In spite of Tuesday’s rally in government debt, 10-year yields are up 35 basis points on the month , reflecting inflation risks from higher energy costs and diminished likelihood of Federal Reserve interest-rate cuts in the coming year. “The risks to the growth outlook are more severe,” said Brij Khurana , a portfolio manager at Wellington Management. “Three months ago, we were talking about AI continuing to be this massive disinflationary growth impact to the economy and now we’re talking about a supply-side shock that the Fed can really do very little about.” Federal Reserve Chair Jerome Powell on Monday reiterated his view that “our policy is in a good place for us to wait and see” how the energy shock unfolds. But traders haven’t waited to price out interest-rate cuts that the Trump administration has long called for . Futures show no rate reductions fully priced in for any central bank policy meeting through July next year. By contrast, at the end of last month, some 75 basis points of easing was anticipated. Even Fed Governor Stephen Miran , Trump’s former chief economist, has tempered his call for rate cuts — though he cited higher-than-expected inflation readings rather than the Iran war. That speaks to a broader backdrop of worry for the administration, amid tariff hikes that continue to push price increases well past the Fed’s 2% inflation target. The latest dynamic for economists and investors to incorporate is the shuttering of the Hormuz Strait, through which 20% of global oil pre...
Eli Lilly and Novo Nordisk aren't the only drugmakers in the weight-loss market, though they are the leaders and attract most of the attention from investors and analysts interested in this growing field. Another, smaller company, Rhythm Pharmaceuticals (NASDAQ: RYTM) , markets an anti-obesity medicine that recently earned a label expansion from U.S. regulators. What do recent developments mean fo...
Eli Lilly and Novo Nordisk aren't the only drugmakers in the weight-loss market, though they are the leaders and attract most of the attention from investors and analysts interested in this growing field. Another, smaller company, Rhythm Pharmaceuticals (NASDAQ: RYTM) , markets an anti-obesity medicine that recently earned a label expansion from U.S. regulators. What do recent developments mean for this biotech's prospects? Image source: Getty Images. Rhythm Pharmaceuticals develops medicines to treat obesity caused by rare conditions. The company's Imcivree has been approved for chronic weight management in patients with certain protein deficiencies that lead to weight gain since 2020. Imcivree is Rhythm Pharmaceuticals' only product on the market right now, and its sales are growing at a good clip. In 2025, the biotech's total revenue came in at $189.8 million, up almost 46% compared to the previous fiscal year. Continue reading
Trump responded to the ruling by complaining that the National Trust for Historic Preservation doesn't appreciate his efforts at "sprucing up" Washington's buildings. (Image credit: Heather Diehl)
Trump responded to the ruling by complaining that the National Trust for Historic Preservation doesn't appreciate his efforts at "sprucing up" Washington's buildings. (Image credit: Heather Diehl)
narvo vexar Uniti Group ( UNIT ) soared 14% amid a report that T-Mobile US ( TMUS ) and TPG ( TPG ) are among parties looking at potentially buying assets of Uniti. T-Mobile ( TMUS ) is interested in Uniti's Kinetic fiber-to-the-home business, while TPG ( TPG ) wants the enterprise fiber side, according to a TMT Finance report on Tuesday, which cited unidentified sources. One source told the publi...
narvo vexar Uniti Group ( UNIT ) soared 14% amid a report that T-Mobile US ( TMUS ) and TPG ( TPG ) are among parties looking at potentially buying assets of Uniti. T-Mobile ( TMUS ) is interested in Uniti's Kinetic fiber-to-the-home business, while TPG ( TPG ) wants the enterprise fiber side, according to a TMT Finance report on Tuesday, which cited unidentified sources. One source told the publication that T-Mobile ( TMUS ) and TPG could be partnering for an offer for the entire company, according to the report. Uniti ( UNIT ) hasn't started a formal sales process, though it's seeing interest from several parties, the report said. More on Uniti Group Uniti Group's Surge Was Well Deserved Uniti Group Inc. (UNIT) Q4 2025 Earnings Call Transcript Uniti Group Inc. 2025 Q4 - Results - Earnings Call Presentation Uniti Group targets up to $655M in Kinetic consumer fiber revenue for 2026 while accelerating infrastructure builds Uniti Group issues solid 2026 guidance after Q4 revenue, adjusted EBITDA beat
Taking 60 seconds to listen to a simple tone could make your next trip more enjoyable. | Image: Samsung Samsung released a new free app today called Hearapy, now available for Android devices through the Google Play store , that it claims can reduce the symptoms of motion sickness using just sound. The app's functionality is very straightforward. It plays a low 100Hz sine wave tone through a pair ...
Taking 60 seconds to listen to a simple tone could make your next trip more enjoyable. | Image: Samsung Samsung released a new free app today called Hearapy, now available for Android devices through the Google Play store , that it claims can reduce the symptoms of motion sickness using just sound. The app's functionality is very straightforward. It plays a low 100Hz sine wave tone through a pair of connected headphones for 60 seconds. This is supposed to stimulate the vestibular system - the parts of the inner ear that are responsible for orientation and maintaining balance. The app allows the duration of the tone to be adjusted between 40 to 120 seconds, but a full minute of listening is supposed to provide relief from motion sickeness symp … Read the full story at The Verge.
Funtap/iStock via Getty Images Fast Facts Capital Group US Multi-Sector Income ETF ( CGMS ) is an actively managed fund in the Multisector Bond category launched on 10/25/2022. CGMS holds about 1500 securities from 694 issuers, with a 30-day SEC yield of 5.72%, a trailing 12-month yield of 6.13%, an average yield-to-worst of 6.7%, and an expense ratio of 0.39%. Distributions are paid monthly. It i...
Funtap/iStock via Getty Images Fast Facts Capital Group US Multi-Sector Income ETF ( CGMS ) is an actively managed fund in the Multisector Bond category launched on 10/25/2022. CGMS holds about 1500 securities from 694 issuers, with a 30-day SEC yield of 5.72%, a trailing 12-month yield of 6.13%, an average yield-to-worst of 6.7%, and an expense ratio of 0.39%. Distributions are paid monthly. It is a large and liquid ETF, with $4.5 billion of AUM (assets under management) and an average daily dollar volume of $28 million. The sponsor, Capital Group, is one of the oldest and largest investment management companies. It was founded in 1931, has over $3.2 trillion in AUM, and is headquartered in Los Angeles. Strategy As described in the prospectus by Capital Group , Normally, the fund will invest its assets across three primary sectors: high-yield corporate debt, investment grade corporate debt and securitized debt. (…) The fund may opportunistically invest in other sectors including, but not limited to, U.S. government debt, municipal debt and non-corporate credit. The fund may invest up to 20% of assets in securities of international issuers and may use derivatives (futures contracts and swaps). Investing decisions are made by a team of portfolio managers based on their professional judgment. The turnover rate was 52% in the most recent fiscal year and 41% in the previous year. Portfolio The fund has about 88% of its asset value in securities of U.S. issuers, with a focus on high-yield corporate bonds (37.2%) and investment-grade corporate bonds (35.7%). Sector breakdown % of assets (Chart: author; data: Capital Group) The fund has a middling credit risk, with 51% of assets in securities with an investment-grade rating. Credit quality profile % of assets (Chart: author; data: Capital Group) The portfolio has an effective duration of 4.4 years, pointing to moderate interest rate risk. A 1% variation in interest rates is expected to cause a roughly 4.4% move in the ETF'...
Sundry Photography/iStock Editorial via Getty Images Lockheed Martin ( LMT ) on Tuesday said it has launched a new facility designed to accelerate the development and early production of advanced defense systems for U.S. government customers, as the Pentagon pushes for faster procurement timelines. Artist rendering of a Lockheed Martin rapid fielding center (Lockheed Martin) The company’s Rapid Fi...
Sundry Photography/iStock Editorial via Getty Images Lockheed Martin ( LMT ) on Tuesday said it has launched a new facility designed to accelerate the development and early production of advanced defense systems for U.S. government customers, as the Pentagon pushes for faster procurement timelines. Artist rendering of a Lockheed Martin rapid fielding center (Lockheed Martin) The company’s Rapid Fielding Center is intended to bring design, testing and prototype manufacturing into a single, integrated environment. By situating engineering teams close to production equipment and factory workers, the facility allows for faster iteration and real-time feedback during development, according to the company. Executives said the approach is meant to shorten the timeline from concept to early production, with systems that traditionally took years to develop now potentially moving through the process in a matter of months. The company also indicated that the modular layout of the facility can be adjusted to accommodate different programs, helping refine manufacturing processes before systems transition to full-scale production. The investment comes as a new generation of defense technology companies, including Anduril Industries , is challenging traditional approaches to weapons development. Unlike established contractors that often build systems in response to detailed government specifications, newer entrants have adopted a more commercial, product-driven model that funds development internally and delivers ready-made systems to customers. These companies also emphasize software-centric design and rapid iteration, integrating artificial intelligence and autonomous capabilities into hardware platforms and updating systems continuously after deployment. In manufacturing, firms such as Anduril are experimenting with scalable production techniques inspired by commercial industries, including the use of off-the-shelf components and “software-defined” factories intended to acceler...
shapecharge/E+ via Getty Images Markets have been rattled by escalating Middle East tensions. Jeff Evans, VP, Director and Lead for Empirical Research and PM Support with TD Asset Management, breaks down how investors are shifting to defensive and quality stocks in a search for stability. Transcript Greg Bonnell: Markets have been volatile as the Middle East conflict continues, but under the surfa...
shapecharge/E+ via Getty Images Markets have been rattled by escalating Middle East tensions. Jeff Evans, VP, Director and Lead for Empirical Research and PM Support with TD Asset Management, breaks down how investors are shifting to defensive and quality stocks in a search for stability. Transcript Greg Bonnell: Markets have been volatile as the Middle East conflict continues, but under the surface, there are some shifts taking place. Joining us now to discuss is Jeff Evans from TD Asset Management. Jeff, great to have you back. Everyone is trying to navigate this market and figure out what's going on. Let's talk about the implications of the conflict. Jeff Evans: First of all, great to be back. Always a pleasure to be here. Thanks for having me on. And yeah, it's been not just one year, but multiple years now of volatility in the markets. This, of course, just being the latest incident to come in. We've had this now for the past year with a lot of tariff turmoil and other geopolitical news. Take it back the last five years, we've had inflation, interest rates, COVID. Seems to be just one shock after another hitting the markets. I think when you get into these periods of volatility and uncertainty, the important thing is to take a step back and look at things at a bigger picture level. And for me, that is, what drives markets over the longer term? Ultimately, it's earnings. If earnings go up, it may not happen right away, but eventually, the market tends to recognize that. You do tend to see stock prices follow earnings over the long term. It's a very important anchor. And so really the key here is, let's just take a step back and see what's happening with earnings growth and where earnings growth still is in the market. Of course, over the past 10 to 15 years, it's really been about the US and the US tech stocks. That's been the dominant source of earnings growth. What you started to see last year was interesting. It was the first year in really 15 years where ear...